How Medsol AI Aims To Promote Early And Accurate Diagnosis Of Breast Cancer
How Medsol AI Aims To Promote Early And Accurate Diagnosis Of Breast Cancer. Medsol AI is an innovation-driven community of members passionate about patient-centered outcomes with the latest AI solutions for diagnostic imaging. Medsol AI solutions promotes, early and accurate diagnosis of breast cancer, leading to a significant reduction in mortality rates associated with breast cancer.
Medsol’s vision is to become a world leader in affordable, diagnostic Artificial Intelligence and Deep machine learning systems for healthcare. The company is striving to provide comprehensive AI and DML services across all healthcare clinics of Africa and beyond, through key stakeholder collaboration in the field of healthcare.
By providing AI systems at the grassroots level for healthcare professionals and hosting education workshops in rural settings for patients, the company aims to reduce overall mortality rates by 2025 for breast cancer. Its social impact will be seen by 2025 when South Africans have increased life expectancy from education workshops and that clinics have improved diagnostic success rates by using its AI system.
Medsol co-markets its product alongside Clarius wireless ultrasound probes with clarity, quality and cost-effective options for Point of Care ultrasound (POCUS). Its product focuses on patient-based outcomes, with a unique educational platform for patients diagnosed with breast cancer to ensure they are informed and empowered with the necessary information going forward during their treatment journey.
